ADMA EBITDA Growth
Adma Biologics Inc · EBITDA Growth
ADMA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported42.84%period ending
ADMA TTM EBITDA YoY % (17.91% → 42.84%)
Year-over-year change
High-resolution chart · PNG
ADMA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 42.8437% | |
| 37.7714% | |
| 33.9727% | |
| 74.1658% | |
| 140.9287% | |
| 473.3755% | |
| 2,784.9604% | |
| 900.1092% | |
| 884.4645% | |
| 254.7389% | |
| 112.9565% | |
| 121.1295% | |
| 83.5004% | |
| 69.3699% | |
| 25.5843% | |
| 16.9948% | |
| 6.8389% | |
| -1.952% | |
| 11.2434% | |
| -8.8648% | |
| -19.6158% | |
| -41.3972% | |
| -66.0418% | |
| -15.7812% | |
| 5.4023% | |
| 20.8038% | |
| 36.542% | |
| 12.9932% | |
| 4.7208% | |
| -8.7661% | |
| -50.2727% | |
| -64.0737% | |
| -144.0485% | |
| -156.2338% | |
| -124.5848% | |
| -83.952% | |
| -18.8019% | |
| -15.4833% | |
| -10.9551% | |
| -15.3295% | |
| -36.0899% | |
| -21.36% | |
| 4.1575% | |
| 11.4763% | |
| 18.358% | |
| 23.0996% | |
| -7.7016% | |
| -21.4657% | |
| -15.7867% | |
| -65.2227% | |
| -72.0993% | |
| -172.5177% | |
| -498.7748% | |
| -780.6221% | |
| -28,258.9533% | |
| -18,559.5962% | |
| -8,710.8714% | |
| -5,204.5491% | |
| -35.2159% | |
| -26.4107% | |
| 99.3099% | |
| 99.9062% | |
| 99.936% | |
| 99.949% | |
| 93.9091% | |
| 59.6121% | |
| 41.3466% | |
| -9.597% | |
| 5.1783% | |
| 11.9781% | |
| 17.9089% |